HEADER IMMUNE SYSTEM 25-MAY-14 4QGT TITLE THE CRYSTAL STRUCTURE OF HUMAN IGG FC DOMAIN WITH ENHANCED AROMATIC TITLE 2 SEQUON COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATITIS B VIRUS RECEPTOR BINDING PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606 KEYWDS IGG1, IMMUNOGLOBULIN-LIKE BETA-SANDWICH, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR L.KONG,S.C.CONNELLY,I.A.WILSON REVDAT 4 20-SEP-23 4QGT 1 HETSYN REVDAT 3 29-JUL-20 4QGT 1 COMPND REMARK SEQADV HETNAM REVDAT 3 2 1 LINK SITE ATOM REVDAT 2 23-NOV-16 4QGT 1 JRNL REVDAT 1 08-APR-15 4QGT 0 JRNL AUTH W.CHEN,L.KONG,S.CONNELLY,J.M.DENDLE,Y.LIU,I.A.WILSON, JRNL AUTH 2 E.T.POWERS,J.W.KELLY JRNL TITL STABILIZING THE CH2 DOMAIN OF AN ANTIBODY BY ENGINEERING IN JRNL TITL 2 AN ENHANCED AROMATIC SEQUON. JRNL REF ACS CHEM.BIOL. V. 11 1852 2016 JRNL REFN ISSN 1554-8929 JRNL PMID 27128252 JRNL DOI 10.1021/ACSCHEMBIO.5B01035 REMARK 2 REMARK 2 RESOLUTION. 2.99 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1496) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.99 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.85 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 87.9 REMARK 3 NUMBER OF REFLECTIONS : 10005 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.299 REMARK 3 R VALUE (WORKING SET) : 0.298 REMARK 3 FREE R VALUE : 0.326 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.180 REMARK 3 FREE R VALUE TEST SET COUNT : 518 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.8580 - 4.7444 0.88 2446 133 0.3174 0.3043 REMARK 3 2 4.7444 - 3.7663 0.89 2399 121 0.2655 0.3499 REMARK 3 3 3.7663 - 3.2903 0.90 2413 129 0.2878 0.3156 REMARK 3 4 3.2903 - 2.9895 0.84 2229 135 0.3303 0.3645 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.530 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 35.540 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 3552 REMARK 3 ANGLE : 0.846 4832 REMARK 3 CHIRALITY : 0.045 562 REMARK 3 PLANARITY : 0.013 599 REMARK 3 DIHEDRAL : 12.644 1346 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4QGT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-JUN-14. REMARK 100 THE DEPOSITION ID IS D_1000086036. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-NOV-13 REMARK 200 TEMPERATURE (KELVIN) : 200.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : SIDE SCATTERING BENT CUBE-ROOT I REMARK 200 -BEAM SINGLE CRYSTAL; ASYMMETRIC REMARK 200 CUT 4.965 DEGS REMARK 200 OPTICS : RH COATED FLAT MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : 2.990 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.5 REMARK 200 DATA REDUNDANCY : 2.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08200 REMARK 200 FOR THE DATA SET : 12.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3AVE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM HEPES, 30% PEG 1000 CRYO: +10% REMARK 280 ETHYLENE GLYCOL, PH 7.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 298KK REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 77.03600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.59500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 77.03600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.59500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 43.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE A 215 REMARK 465 GLU A 216 REMARK 465 PRO A 217 REMARK 465 LYS A 218 REMARK 465 SER A 219 REMARK 465 CYS A 220 REMARK 465 ASP A 221 REMARK 465 LYS A 222 REMARK 465 THR A 223 REMARK 465 HIS A 224 REMARK 465 THR A 225 REMARK 465 CYS A 226 REMARK 465 PRO A 227 REMARK 465 PRO A 228 REMARK 465 CYS A 229 REMARK 465 PRO A 230 REMARK 465 ALA A 231 REMARK 465 PRO A 232 REMARK 465 GLU A 233 REMARK 465 LEU A 234 REMARK 465 LEU A 235 REMARK 465 GLY A 236 REMARK 465 ASN A 325 REMARK 465 LYS A 326 REMARK 465 SER A 444 REMARK 465 PRO A 445 REMARK 465 GLY A 446 REMARK 465 LYS A 447 REMARK 465 PHE B 215 REMARK 465 GLU B 216 REMARK 465 PRO B 217 REMARK 465 LYS B 218 REMARK 465 SER B 219 REMARK 465 CYS B 220 REMARK 465 ASP B 221 REMARK 465 LYS B 222 REMARK 465 THR B 223 REMARK 465 HIS B 224 REMARK 465 THR B 225 REMARK 465 CYS B 226 REMARK 465 PRO B 227 REMARK 465 PRO B 228 REMARK 465 CYS B 229 REMARK 465 PRO B 230 REMARK 465 ALA B 231 REMARK 465 PRO B 232 REMARK 465 GLU B 233 REMARK 465 LEU B 234 REMARK 465 LEU B 235 REMARK 465 GLY B 236 REMARK 465 SER B 444 REMARK 465 PRO B 445 REMARK 465 GLY B 446 REMARK 465 LYS B 447 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O MET B 358 NZ LYS B 414 1.62 REMARK 500 ND2 ASN A 297 C1 NAG C 1 1.87 REMARK 500 O MET A 358 NZ LYS A 414 1.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 271 C - N - CD ANGL. DEV. = -14.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 267 177.50 99.90 REMARK 500 GLU A 269 -8.25 92.98 REMARK 500 LYS A 290 -59.66 -122.53 REMARK 500 ARG A 292 -175.22 78.47 REMARK 500 ASN A 315 32.41 -90.55 REMARK 500 PRO A 374 -168.50 -78.70 REMARK 500 ASP A 376 104.38 -59.17 REMARK 500 SER B 298 4.39 84.92 REMARK 500 PRO B 353 -177.14 -68.53 REMARK 500 ASN B 390 67.71 64.44 REMARK 500 ASP B 401 26.05 -75.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAG C 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3AVE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE FUCOSYLATED FC FRAGMENT FROM HUMAN REMARK 900 IMMUNOGLOBULIN G1 REMARK 900 RELATED ID: 4BM7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF IGG FC F241A MUTANT WITH NATIVE GLYCOSYLATION REMARK 900 RELATED ID: 2WAH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN IGG1 FC GLYCOFORM (MAN9GLCNAC2) DBREF 4QGT A 216 447 UNP Q6PYX1 Q6PYX1_HUMAN 117 348 DBREF 4QGT B 216 447 UNP Q6PYX1 Q6PYX1_HUMAN 117 348 SEQADV 4QGT PHE A 215 UNP Q6PYX1 EXPRESSION TAG SEQADV 4QGT PHE A 295 UNP Q6PYX1 GLN 196 ENGINEERED MUTATION SEQADV 4QGT ALA A 296 UNP Q6PYX1 TYR 197 ENGINEERED MUTATION SEQADV 4QGT PHE B 215 UNP Q6PYX1 EXPRESSION TAG SEQADV 4QGT PHE B 295 UNP Q6PYX1 GLN 196 ENGINEERED MUTATION SEQADV 4QGT ALA B 296 UNP Q6PYX1 TYR 197 ENGINEERED MUTATION SEQRES 1 A 233 PHE GLU PRO LYS SER CYS ASP LYS THR HIS THR CYS PRO SEQRES 2 A 233 PRO CYS PRO ALA PRO GLU LEU LEU GLY GLY PRO SER VAL SEQRES 3 A 233 PHE LEU PHE PRO PRO LYS PRO LYS ASP THR LEU MET ILE SEQRES 4 A 233 SER ARG THR PRO GLU VAL THR CYS VAL VAL VAL ASP VAL SEQRES 5 A 233 SER HIS GLU ASP PRO GLU VAL LYS PHE ASN TRP TYR VAL SEQRES 6 A 233 ASP GLY VAL GLU VAL HIS ASN ALA LYS THR LYS PRO ARG SEQRES 7 A 233 GLU GLU PHE ALA ASN SER THR TYR ARG VAL VAL SER VAL SEQRES 8 A 233 LEU THR VAL LEU HIS GLN ASP TRP LEU ASN GLY LYS GLU SEQRES 9 A 233 TYR LYS CYS LYS VAL SER ASN LYS ALA LEU PRO ALA PRO SEQRES 10 A 233 ILE GLU LYS THR ILE SER LYS ALA LYS GLY GLN PRO ARG SEQRES 11 A 233 GLU PRO GLN VAL TYR THR LEU PRO PRO SER ARG GLU GLU SEQRES 12 A 233 MET THR LYS ASN GLN VAL SER LEU THR CYS LEU VAL LYS SEQRES 13 A 233 GLY PHE TYR PRO SER ASP ILE ALA VAL GLU TRP GLU SER SEQRES 14 A 233 ASN GLY GLN PRO GLU ASN ASN TYR LYS THR THR PRO PRO SEQRES 15 A 233 VAL LEU ASP SER ASP GLY SER PHE PHE LEU TYR SER LYS SEQRES 16 A 233 LEU THR VAL ASP LYS SER ARG TRP GLN GLN GLY ASN VAL SEQRES 17 A 233 PHE SER CYS SER VAL MET HIS GLU ALA LEU HIS ASN HIS SEQRES 18 A 233 TYR THR GLN LYS SER LEU SER LEU SER PRO GLY LYS SEQRES 1 B 233 PHE GLU PRO LYS SER CYS ASP LYS THR HIS THR CYS PRO SEQRES 2 B 233 PRO CYS PRO ALA PRO GLU LEU LEU GLY GLY PRO SER VAL SEQRES 3 B 233 PHE LEU PHE PRO PRO LYS PRO LYS ASP THR LEU MET ILE SEQRES 4 B 233 SER ARG THR PRO GLU VAL THR CYS VAL VAL VAL ASP VAL SEQRES 5 B 233 SER HIS GLU ASP PRO GLU VAL LYS PHE ASN TRP TYR VAL SEQRES 6 B 233 ASP GLY VAL GLU VAL HIS ASN ALA LYS THR LYS PRO ARG SEQRES 7 B 233 GLU GLU PHE ALA ASN SER THR TYR ARG VAL VAL SER VAL SEQRES 8 B 233 LEU THR VAL LEU HIS GLN ASP TRP LEU ASN GLY LYS GLU SEQRES 9 B 233 TYR LYS CYS LYS VAL SER ASN LYS ALA LEU PRO ALA PRO SEQRES 10 B 233 ILE GLU LYS THR ILE SER LYS ALA LYS GLY GLN PRO ARG SEQRES 11 B 233 GLU PRO GLN VAL TYR THR LEU PRO PRO SER ARG GLU GLU SEQRES 12 B 233 MET THR LYS ASN GLN VAL SER LEU THR CYS LEU VAL LYS SEQRES 13 B 233 GLY PHE TYR PRO SER ASP ILE ALA VAL GLU TRP GLU SER SEQRES 14 B 233 ASN GLY GLN PRO GLU ASN ASN TYR LYS THR THR PRO PRO SEQRES 15 B 233 VAL LEU ASP SER ASP GLY SER PHE PHE LEU TYR SER LYS SEQRES 16 B 233 LEU THR VAL ASP LYS SER ARG TRP GLN GLN GLY ASN VAL SEQRES 17 B 233 PHE SER CYS SER VAL MET HIS GLU ALA LEU HIS ASN HIS SEQRES 18 B 233 TYR THR GLN LYS SER LEU SER LEU SER PRO GLY LYS MODRES 4QGT ASN B 297 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET MAN C 4 11 HET NAG C 5 14 HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET MAN D 4 11 HET NAG D 5 14 HET MAN D 6 11 HET NAG D 7 14 HET FUC D 8 10 HET GOL B 509 6 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM GOL GLYCEROL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 NAG 7(C8 H15 N O6) FORMUL 3 BMA 2(C6 H12 O6) FORMUL 3 MAN 3(C6 H12 O6) FORMUL 4 FUC C6 H12 O5 FORMUL 5 GOL C3 H8 O3 FORMUL 6 HOH *3(H2 O) HELIX 1 1 LYS A 246 LEU A 251 1 6 HELIX 2 2 LEU A 309 ASN A 315 1 7 HELIX 3 3 GLU A 356 LYS A 360 5 5 HELIX 4 4 LYS A 414 GLY A 420 1 7 HELIX 5 5 LEU A 432 TYR A 436 5 5 HELIX 6 6 LYS B 246 MET B 252 1 7 HELIX 7 7 LEU B 309 ASN B 315 1 7 HELIX 8 8 SER B 354 THR B 359 1 6 HELIX 9 9 LYS B 414 GLN B 419 1 6 HELIX 10 10 LEU B 432 TYR B 436 5 5 SHEET 1 A 4 SER A 239 PHE A 243 0 SHEET 2 A 4 GLU A 258 VAL A 264 -1 O VAL A 262 N PHE A 241 SHEET 3 A 4 VAL A 302 THR A 307 -1 O SER A 304 N CYS A 261 SHEET 4 A 4 ALA A 287 THR A 289 -1 N LYS A 288 O VAL A 305 SHEET 1 B 4 VAL A 282 GLU A 283 0 SHEET 2 B 4 LYS A 274 VAL A 279 -1 N VAL A 279 O VAL A 282 SHEET 3 B 4 TYR A 319 SER A 324 -1 O SER A 324 N LYS A 274 SHEET 4 B 4 ILE A 332 ILE A 336 -1 O ILE A 332 N VAL A 323 SHEET 1 C 4 GLN A 347 LEU A 351 0 SHEET 2 C 4 GLN A 362 PHE A 372 -1 O LEU A 368 N TYR A 349 SHEET 3 C 4 PHE A 404 ASP A 413 -1 O LEU A 406 N VAL A 369 SHEET 4 C 4 TYR A 391 THR A 393 -1 N LYS A 392 O LYS A 409 SHEET 1 D 4 GLN A 347 LEU A 351 0 SHEET 2 D 4 GLN A 362 PHE A 372 -1 O LEU A 368 N TYR A 349 SHEET 3 D 4 PHE A 404 ASP A 413 -1 O LEU A 406 N VAL A 369 SHEET 4 D 4 VAL A 397 LEU A 398 -1 N VAL A 397 O PHE A 405 SHEET 1 E 3 ALA A 378 GLU A 382 0 SHEET 2 E 3 VAL A 422 MET A 428 -1 O SER A 426 N GLU A 380 SHEET 3 E 3 THR A 437 SER A 442 -1 O THR A 437 N VAL A 427 SHEET 1 F 4 SER B 239 PHE B 243 0 SHEET 2 F 4 GLU B 258 VAL B 266 -1 O THR B 260 N PHE B 243 SHEET 3 F 4 TYR B 300 THR B 307 -1 O SER B 304 N CYS B 261 SHEET 4 F 4 LYS B 288 THR B 289 -1 N LYS B 288 O VAL B 305 SHEET 1 G 4 VAL B 282 VAL B 284 0 SHEET 2 G 4 VAL B 273 VAL B 279 -1 N VAL B 279 O VAL B 282 SHEET 3 G 4 TYR B 319 ASN B 325 -1 O LYS B 320 N TYR B 278 SHEET 4 G 4 ILE B 332 ILE B 336 -1 O ILE B 336 N TYR B 319 SHEET 1 H 4 GLN B 347 LEU B 351 0 SHEET 2 H 4 GLN B 362 PHE B 372 -1 O LEU B 368 N TYR B 349 SHEET 3 H 4 PHE B 404 ASP B 413 -1 O LEU B 406 N VAL B 369 SHEET 4 H 4 TYR B 391 THR B 393 -1 N LYS B 392 O LYS B 409 SHEET 1 I 4 GLN B 347 LEU B 351 0 SHEET 2 I 4 GLN B 362 PHE B 372 -1 O LEU B 368 N TYR B 349 SHEET 3 I 4 PHE B 404 ASP B 413 -1 O LEU B 406 N VAL B 369 SHEET 4 I 4 VAL B 397 LEU B 398 -1 N VAL B 397 O PHE B 405 SHEET 1 J 4 GLN B 386 PRO B 387 0 SHEET 2 J 4 ALA B 378 SER B 383 -1 N SER B 383 O GLN B 386 SHEET 3 J 4 VAL B 422 MET B 428 -1 O SER B 426 N GLU B 380 SHEET 4 J 4 THR B 437 SER B 442 -1 O LYS B 439 N CYS B 425 SSBOND 1 CYS A 261 CYS A 321 1555 1555 2.03 SSBOND 2 CYS A 367 CYS A 425 1555 1555 2.03 SSBOND 3 CYS B 261 CYS B 321 1555 1555 2.03 SSBOND 4 CYS B 367 CYS B 425 1555 1555 2.03 LINK ND2 ASN B 297 C1 NAG D 1 1555 1555 1.50 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.42 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.41 LINK O6 BMA C 3 C1 MAN C 4 1555 1555 1.42 LINK O2 MAN C 4 C1 NAG C 5 1555 1555 1.42 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.42 LINK O6 NAG D 1 C1 FUC D 8 1555 1555 1.44 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.41 LINK O3 BMA D 3 C1 MAN D 4 1555 1555 1.43 LINK O6 BMA D 3 C1 MAN D 6 1555 1555 1.40 LINK O2 MAN D 4 C1 NAG D 5 1555 1555 1.43 LINK O2 MAN D 6 C1 NAG D 7 1555 1555 1.42 CISPEP 1 TYR A 373 PRO A 374 0 0.61 CISPEP 2 TYR B 373 PRO B 374 0 -0.95 CRYST1 154.072 49.190 75.536 90.00 104.21 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006490 0.000000 0.001643 0.00000 SCALE2 0.000000 0.020329 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013656 0.00000